Biografi/ Biography :
Dr. Mohd.Heikal Mohd.Yunus, is a senior medical lecturer in the Department of Physiology, Faculty of Medicine, National University of Malaysia since March 2009. He has been an Associate Research Fellow at the Tissue Engineering Center since 2009. He obtained a Doctor of Medicine (MD) and Master in Medical Science Physiology from the National University of Malaysia under the supervision of Professor Dato ` Dr. Ruszymah Hajj Idrus. He was subsequently awarded a PhD (Pharmacology) specialized in Regenerative Medicine from the same university. His expertise in the field of Regenerative Medicine was recognized when he was appointed as a Working Committee of the Amendment of the Human Tissue Act 1974 by the Ministry of Health Malaysia in 2017. He was also appointed cGMP Laboratory Clinical Trials Coordinator for cell therapy and tissue engineering under the auspices of Centre for Research UKM in 2008 and Chief Clinical Officer at Cell Tissue Technology Sdn. Berhad in 2014 where he was assigned the responsibility of screening patients who were potentially treated using the ‘MyDerm` product and subsequently served as a liaison between the production division and the surgeon. Dr. Mohd Heikal is a specialist in the field of Regenerative Medicine and his research focuses on the areas of skin tissue engineering, tracheal and cartilage tissue. His research focuses on the reconstruction of human tissues through tissue engineering methods from autologous samples where replacement tissue is manufactured using a portion of the patient`s own tissue to treat injuries or defects in parts of the body. He has received various awards both inside and outside the UKM. In 2014, Dr. Mohd. Heikal was selected as the finalist in the final of the Global Innovation through Science and Technology (GIST) initiative’s Technology-Idea (Tech-I) at the Global Entrepreneurship Summit (GES) in Marrakech, Morocco. He was one of 15 participants selected from over 70 countries around the South America, Africa, and Asia. He was also the winner of the
yogeswaran a/l lokanathan;mohd rafizul bin mohd yusof;mohd heikal bin mohd yunus;ng min hwei;muhammad da`in bin yazid;chin kok yong;law jia xian;sharen @ sharen aini binti shamsuddin;mohd asyraf bin mat afandi;rabiatul adawiyah binti razali. (2024). efficacy study of allogeneic mesenchymal stem cell therapy for treatment for metabolic syndrome in animal model. - . .
yogeswaran a/l lokanathan;ruszymah binti haji idrus;norazlina binti mohamed;mohd heikal bin mohd yunus;shamsul azhar bin shah;anis ezdiana binti abdul aziz;ng min hwei;shiplu roy chowdhury;muhammad da`in bin yazid;chow yock ping;chin kok yong;law jia xian. (2024). program: identifying degenerative disease burden among elderly population in klang valley and innovative intervention modalities. sub project: animal study on the safety and efficacy of allogeneic mesenchymal stromal/ stem cell therapy in delaying the pr. - . .
alvin man lung chan, angela min hwei ng, mohd heikal mohd yunus, ruszymah hj idrus, jia xian law, muhammad dain yazid, kok-yong chin, mohd rafizul mohd yusof, see nguan ng, benson koh & yogeswaran lokanathan. (2024). single high-dose intravenous injection of wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome. - stem cell research & therapy. 1-19.
yi ting lee, mohd heikal mohd yunus, muhammad dain yazid and azizah ugusman. (2024). unraveling the path to osteoarthritis management: targeting chondrocyte apoptosis for therapeutic intervention. - frontiers in cell and developmental biology. 1-16.
mohd heikal my, ahmad musab ah, mohd fauzi mb, jaya kumar m. (2024). the fabrication of gelatin-elastin-nanocellulose composite bioscaffold as a potential acellular skin substitute. - medicine & health. 20.
alvin man lung chan, angela min hwei ng, mohd heikal mohd yunus, ruszymah hj idrus, jia xian law, muhammad dain yazid, kok-yong chin, mohd rafizul mohd yusof, see nguan ng, benson koh & yogeswaran lokanathan. (2024). single high-dose intravenous injection of wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome. - stem cell research & therapy. 1-19.
yi ting lee, mohd heikal mohd yunus, muhammad dain yazid and azizah ugusman. (2024). unraveling the path to osteoarthritis management: targeting chondrocyte apoptosis for therapeutic intervention. - frontiers in cell and developmental biology. 1-16.
wafa ali batarfi, mohd heikal mohd yunus and adila a. hamid. (2023). the effect of hydroxytyrosol in type ii epithelial-mesenchymal transition in human skin wound healing. - molecules. 1-14.
benson koh, nadiah sulaiman, mohd fauzi mh busra, law jia xian, ng min hwei, too lih yuan, abdul ghani nur azurah, mohd heikal mohd yunus, ruszymah bt hj idrus, muhammad dain yazid.. (2023). a three-dimensional xeno-free culture condition for wharton's jelly-mesenchymal stem cells: the pros and cons. - international journal of molecular sciences. 1-18.
yt jun cheah, mohd heikal mohd yunus, mh busra fauzi, yasuhiko tabata, yosuke hiraoka, shou jin phang, min rui chia, muhamad ramdzan buyong, muhammad dain yazid. (2023). gelatin-chitosan-cellulose nanocrystals as an acellular scafold for wound healing application: fabrication, characterisation and cytocompatibility towards primary human skin cells. - cellulose. 5071-5092.
mohd heikal mohd yunus, muhammad abid nordin, haziq aiman kamal bahri. (2020). pathophysiological perspective of osteoarthritis. - medicina-lithuania. 1-13.
adila a hamid, amilia aminuddin, mohd heikal mohd yunus, jaya kumar murthy, chua kien hui and azizah ugusman. (2020). antioxidative and anti-inflammatory activities of polygonum minus: a review of literature. - reviews in cardiovascular medicine. 275-287.
mohd heikal mohd yunus, ahmad nazrun shuid, mohd fauzi busra, chua kien hui, norzana abdul ghafar & rizal abd rani. (2019). the effect of stichopus chloronotus aqueous extract on human osteoarthritis articular chondrocytes in three-dimensional collagen type i hydrogel in vitro. - sains malaysiana. 1671-1683.
mohd yunus mohd heikal, shuid ahmad nazrun, kien hui chua, abd ghafar norzana. (2019). stichopus chloronotus aqueous extract as a chondroprotective agent for human chondrocytes isolated from osteoarthitis articular cartilage in vitro. - cytotechnology. 521-537.
muhammad mior amirul a, mohd heikal mohd yunus, fauzi mh busra. (2019). genipin-crosslinked gelatin scaffold in tissue engineering: a systematic review. - medicine & health. 1-16.
alvin man lung chan, angela min hwei ng, mohd heikal mohd yunus, ruszymah hj idrus, jia xian law, muhammad dain yazid, kok-yong chin, mohd rafizul mohd yusof, see nguan ng, benson koh & yogeswaran lokanathan. (2024). single high-dose intravenous injection of wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome. - stem cell research & therapy. 1-19.
yi ting lee, mohd heikal mohd yunus, muhammad dain yazid and azizah ugusman. (2024). unraveling the path to osteoarthritis management: targeting chondrocyte apoptosis for therapeutic intervention. - frontiers in cell and developmental biology. 1-16.
wafa ali batarfi, mohd heikal mohd yunus and adila a. hamid. (2023). the effect of hydroxytyrosol in type ii epithelial-mesenchymal transition in human skin wound healing. - molecules. 1-14.
benson koh, nadiah sulaiman, mohd fauzi mh busra, law jia xian, ng min hwei, too lih yuan, abdul ghani nur azurah, mohd heikal mohd yunus, ruszymah bt hj idrus, muhammad dain yazid.. (2023). a three-dimensional xeno-free culture condition for wharton's jelly-mesenchymal stem cells: the pros and cons. - international journal of molecular sciences. 1-18.
yt jun cheah, mohd heikal mohd yunus, mh busra fauzi, yasuhiko tabata, yosuke hiraoka, shou jin phang, min rui chia, muhamad ramdzan buyong, muhammad dain yazid. (2023). gelatin-chitosan-cellulose nanocrystals as an acellular scafold for wound healing application: fabrication, characterisation and cytocompatibility towards primary human skin cells. - cellulose. 5071-5092.
ooi kai shen, shafieq haszman, wong yon nie, emilia soidin, nadhirah hesham, mohd fauzi mh busra, mohd heikal mohd yunus. (2021). physico-chemical characterization of bilayer composite palm tree-based nanocellulose as a potential wound dressing. - malaysian society of pharmacology & physiology (mspp) - 34th scientific meeting 2021. 209-210.
najla shakirah ab halim, azizah ugusman, amilia aminuddin, mohd heikal mohd yunus, mohd faizal ahmad,nur najmi mohamad anuar, adila a hamid. (2021). polygonum minus inhibits tumor necrosis factor alpha-induced endothelial cell migration. - malaysian society of pharmacology & physiology (mspp) - 34th scientific meeting 2021, frontiers in pharmacology. 207-208.
juriza i, ruzanna z, harlina hs, rohaizak m, zulkifli z, fauzi ma, m radniwan, m, razif, m heikal, anisah n, nabishah m, lokman s. (2011). outdoor camps experiential learning activities for teamwork and leadership among medical students. - kongres pengajaran dan pembelajaran ukm, 2010; tanjung keling, melaka (procedia social and behavioural sciences). .
mohd heikal mohd yunus nur adelina a. noruddin ruszymah idrus. (2021). rawatan alternatif stenosis trakea melalui kaedah kejuruteraan tisu. - . 89.
mohd heikal mohd yunus. (2020). sumber laut sebagai penawar osteoartritis. - . 100.
mohd heikal mohd yunus nur adelina a. noruddin ruszymah idrus. (2021). rawatan alternatif stenosis trakea melalui kaedah kejuruteraan tisu. - . 89.
mohd heikal mohd yunus. (2020). sumber laut sebagai penawar osteoartritis. - . 100.
yogeswaran a/l lokanathan;ruszymah binti haji idrus;norazlina binti mohamed;mohd heikal bin mohd yunus;shamsul azhar bin shah;anis ezdiana binti abdul aziz;ng min hwei;shiplu roy chowdhury;muhammad da`in bin yazid;chow yock ping;chin kok yong;law jia xian. (2024). program: identifying degenerative disease burden among elderly population in klang valley and innovative intervention modalities. sub project: animal study on the safety and efficacy of allogeneic mesenchymal stromal/ stem cell therapy in delaying the pr. - . .
yogeswaran a/l lokanathan;mohd rafizul bin mohd yusof;mohd heikal bin mohd yunus;ng min hwei;muhammad da`in bin yazid;chin kok yong;law jia xian;sharen @ sharen aini binti shamsuddin;mohd asyraf bin mat afandi;rabiatul adawiyah binti razali. (2024). efficacy study of allogeneic mesenchymal stem cell therapy for treatment for metabolic syndrome in animal model. - . .
jaya kumar a/l murthy;norhazlina binti abdul wahab;siti fatimah binti ibrahim;norlinah binti mohamed ibrahim;mohd heikal bin mohd yunus;isa bin naina mohamed;shahrul azmin bin md. rani;rashidi mohamed bin pakri mohamed;azizah binti ugusman;nur fudhla bint. (2023). ibro-aprc neuroscience school on neuromics: the yin-yang aspect in translational neuroscience. - . .
tan geok chin, mohd heikal mohd yunus, norliana masbah, hamat hamdi che hassan. (2023). pakej problem-based learning: oh my chest. - . 1-32.
jaya kumar a/l murthy;norhazlina binti abdul wahab;siti fatimah binti ibrahim;norlinah binti mohamed ibrahim;mohd heikal bin mohd yunus;isa bin naina mohamed;shahrul azmin bin md. rani;rashidi mohamed bin pakri mohamed;azizah binti ugusman;nur fudhla bint. (2023). ibro-aprc neuroscience school on neuromics: the yin-yang aspect in translational neuroscience. - . .
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | malaysian palm oil board | 49.5% (2022-11-29 sehingga 2027-01-30) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | davos life science sdn bhd | 49.5% (2022-11-29 sehingga 2027-01-30) |
| ADVANCED PRODUCTION TECHNOLOGY FOR STEM CELL: MASS PRODUCTION WITH BIOREACTOR (PROOF OF CONCEPT) | yakin splendour sdn bhd | 54.5% (2023-01-26 sehingga 2026-07-25) |
| EVALUATION OF SKIN WOUND HEALING EFFICIENCY USING 3D-BIOPRINTED HYBRID HYALURONIC ACID-GELATIN BIOINKS IN DIABETIC SKIN WOUND MICE MODEL. | 3d gens sdn bhd | 81.6% (2024-02-28 sehingga 2025-02-27) |
| EVALUATION OF SKIN WOUND HEALING EFFICIENCY USING 3D-BIOPRINTED HYBRID HYALURONIC ACID-GELATIN BIOINKS IN DIABETIC SKIN WOUND MICE MODEL. | my cytohealth sdn bhd | 81.6% (2024-02-28 sehingga 2025-02-27) |